|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C12N 7/00 |
| (11) | Number of the document | 3400292 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17700386.0 |
| Date of filing the European patent application | 2017-01-09 | |
| (97) | Date of publication of the European application | 2018-11-14 |
| (45) | Date of publication and mention of the grant of the patent | 2020-08-26 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/GB2017/050039 |
| Date | 2017-01-09 |
| (87) | Number | WO 2017/118867 |
| Date | 2017-07-13 |
| (30) | Number | Date | Country code |
| 201600380 | 2016-01-08 | GB | |
| 201600381 | 2016-01-08 | GB | |
| 201600382 | 2016-01-08 | GB |
| (72) |
COFFIN, Robert, GB
|
| (73) |
Replimune Limited,
69 Innovation Drive Milton Park, Abingdon, Oxfordshire OX14 4RQ,
GB
|
| (54) | USE OF AN ONCOLYTIC VIRUS FOR THE TREATMENT OF CANCER |
| USE OF AN ONCOLYTIC VIRUS FOR THE TREATMENT OF CANCER |